HOME >> MEDICINE >> NEWS
UI-led study shows experimental anti-cancer drug also has anti-HIV properties

The results of a study led by a University of Iowa researcher suggest that a drug already undergoing stage I and II clinical trials as a cancer treatment may also have potential as an anti-HIV therapy.

The study, led by David Price, Ph.D., a UI professor of biochemistry working with Matija Peterlin at the University of California San Francisco and Adrian Senderowicz at the National Cancer Institute, found that very low concentrations of flavopiridol, a drug manufactured by Aventis Inc., blocks HIV-1 replication in cell culture experiments. These findings appeared in the July 21 online issue of the Journal of Biological Chemistry.

Flavopiridol strongly hinders the cellular process known as transcription, a multi-step process which results in the production of ribonucleic acid (RNA). Cells use the genetic information encoded by these long RNA molecules to make proteins.

Flavopiridol effectively blocks the action of an enzyme called P-TEFb, which controls one of the steps in the transcription process. In fact, flavopiridol is the most powerful P-TEFb inhibitor to date. In Price's test tube experiments, even extremely low concentrations of flavopiridol were effective at blocking the action of P-TEFb.

P-TEFb is required for transcription of the HIV-1 genome to occur. Flavopiridol inhibits P-TEFb, causing inhibition of transcription. In tests to investigate its effect on HIV-1 infection and viral spread in cultured human cells, Price's team found that the same low concentrations of flavopiridol that inhibited P-TEFb dramatically blocked HIV-1 infection and replication.

"Since P-TEFb is a key factor in HIV-1 infection and flavopiridol blocks HIV-1 propagation in culture, we believe that this substance should be tested as a potential anti-AIDS drug," Price said.

During infection, HIV-1 undergoes mutations in its DNA that allow its proteins to change and become resistant to drugs. This is one of the biggest problems with treatment of HIV. Many
'"/>

Contact: Jennifer Brown
brownj@mail.medicine.uiowa.edu
319-335-9917
University of Iowa
2-Aug-2000


Page: 1 2

Related medicine news :

1. UI-led study indicates surgery is the best treatment for severe Bells palsy paralysis
2. First head-to-head study to compare lidoderm patch and Celebrex in treating pain
3. UMaine study looks at infants and chronic nighttime crying
4. Chronic pain treatments more effective when taken together, new study shows
5. UNC study: Most N.C. family practitioners engage in unrecognized community service
6. New study in Nature demonstrates protection against cell death during heart attack
7. UCSF study offers insight into human circadian rhythms
8. International breast cancer prevention study launches in the United States and Canada
9. UW study shows blacks and Latinos are more satisfied with physicians of the same race
10. Physicians may not be accurate in their confidence levels of their diagnoses, says Pitt study
11. Advertising by academic medical centers may risk eroding public trust, says study

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/3/2020)... ... 03, 2020 , ... The American Medical Spa Association (AmSpa) ... to Saturday, April 10, 2021, at Wynn Las Vegas. The event had previously ... show for non-invasive medical aesthetic practices that brings together owners, physicians, nurse practitioners, ...
(Date:9/1/2020)... ... September 01, 2020 , ... ... practice in Glendale. While the office will be the first to bear ... tummy tucks, buttock augmentation (Brazilian butt lift), as well as rhinoplasty, facial rejuvenation, ...
(Date:9/1/2020)... ... September 01, 2020 , ... Dr. Kiran Gill ... aesthetic surgery of the face, breast, and body. In 2018, she founded Aesthetics ... plastic surgery and aesthetic practice in Southwest Florida. Dr. Gill and her team ...
(Date:8/31/2020)... ... August 31, 2020 , ... Ocean Springs, Mississippi-based ... to medical first responders across the United States. Since the start of the ... equipment (PPE) medical centers , hospitals , firefighters , and ...
(Date:8/31/2020)... ... August 31, 2020 , ... Smile Brands Inc., one ... the United States, today announced the grand opening of another affiliated Bright ... will enjoy convenient hours, a comfortable office, and full-service care at the new ...
Breaking Medicine News(10 mins):
(Date:8/26/2020)... ... August 26, 2020 , ... ScripHessco has announced the release ... breaks down ways that chiropractors can help heal sports injuries and get athletes ... have an unusual amount of pressure and stress on their bodies, so checkups ...
(Date:8/26/2020)... , ... August 26, 2020 ... ... of Eurofins BioPharma Services, Laboratory Testing division, expands its technology footprint with ... of Flow Cytometry platforms available. With industry-leading biomarker solutions, complemented with traditional ...
(Date:8/26/2020)... Va. (PRWEB) , ... August ... ... (CEA) Holdings company today announced that it has entered into definitive agreement ... professionals CME/CE, primarily focused on pharmacists and pharmacy technicians. , CEA ...
Breaking Medicine Technology:
Cached News: